Serial circulating tumor DNA (ctDNA) monitoring in metastatic colorectal cancer (mCRC) reveals dynamic profile of actionable alterations.

Jonathan M. Loree,Jason Henry,Kanwal Pratap Singh Raghav,Christine Megerdichian Parseghian,Kimberly C. Banks,Victoria M. Raymond,Rebecca Nagy,Chuck Hensel,John H. Strickler,Ryan B. Corcoran,Michael J. Overman,AmirAli Talasaz,Scott Kopetz

Serial circulating tumor DNA (ctDNA) monitoring in metastatic colorectal cancer (mCRC) reveals dynamic profile of actionable alterations.

2021

Jonathan M. Loree
Jason Henry
Kanwal Pratap Singh Raghav
Christine Megerdichian Parseghian
Kimberly C. Banks
Victoria M. Raymond
Rebecca Nagy
Chuck Hensel
John H. Strickler
Ryan B. Corcoran
Michael J. Overman
AmirAli Talasaz
Scott Kopetz

3572Background: Serial ctDNA can measure dynamic changes in disease burden over time, however utility of serial profiling to detect changes in actionable alterations remains unclear. Methods: We ev...

Keywords:

Internal medicine
Medicine
Colorectal cancer
Oncology
Circulating tumor DNA

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations